What is MAZE's software and technology licenses, net?

MAZE (MAZE) reported software and technology licenses, net of $4.32M in Q1 2026.

How has MAZE's software and technology licenses, net changed year-over-year?

MAZE's software and technology licenses, net increased by 33.0% year-over-year, from $3.25M to $4.32M.

MAZE MAZE Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Vertex PharmaceuticalsVRTX

——

Septerna, Inc.SEPN

——

Nurix Therapeutics, Inc.NRIX

——

MapLight Therapeutics, Inc. MPLT

——

Oric Pharmaceuticals, Inc.ORIC

——

Zevra Therapeutics, Inc.ZVRA

——

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

See full

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

See full

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

See full

Market cap$1.48B+201%

Enterprise value$1.34B—

P/S7.9×—

Profitability

See full

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

See full

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MAZE's software and technology licenses, net?: MAZE (MAZE) reported software and technology licenses, net of $4.32M in Q1 2026.
How has MAZE's software and technology licenses, net changed year-over-year?: MAZE's software and technology licenses, net increased by 33.0% year-over-year, from $3.25M to $4.32M.